Related references
Note: Only part of the references are listed.An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Cecile Henquet et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
M Arendt et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction
A Caspi et al.
BIOLOGICAL PSYCHIATRY (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
C Henquet et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats
M Schneider et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study
H Verdoux et al.
PSYCHOLOGICAL MEDICINE (2003)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Cannabis induced dopamine release: an in-vivo SPECT study
LNP Voruganti et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2001)